المؤلفون: Muranen TA; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. taru.a.muranen@helsinki.fi.; Research Program in Systems Oncology, Department of Biochemistry and Developmental Biology, University of Helsinki, Helsinki, Finland. taru.a.muranen@helsinki.fi., Morra A; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Khan S; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.; Department of Genetics, HUSLAB, HUS Diagnostic Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.; Individualized Drug Therapy Research Program, University of Helsinki, Helsinki, Finland.; Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland., Barnes DR; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Keeman R; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Leslie G; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Parsons MT; Population Health Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Ahearn TU; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA., Aittomäki K; Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland., Andrulis IL; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Arun BK; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Behrens S; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Bialkowska K; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Bojesen SE; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.; Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Camp NJ; Department of Internal Medicine and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Devilee P; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands., Domchek SM; Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.; LIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany., Evans DG; Prevent Breast Cancer Research Unit, The Nightingale Centre, Manchester University Hospital Foundation NHS Trust, Manchester, UK.; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; Clinical Genetics Service, Manchester Centre for Genomic Medicine, Manchester University Hospitals Foundation Trust, Manchester, UK.; Manchester Breast Centre, Oglesby Cancer Research Centre, The Christie, University of Manchester, Manchester, UK., Gago-Dominguez M; Health Research Institute of Santiago de Compostela Foundation (FIDIS), SERGAS, Cancer Genetics and Epidemiology Group Santiago de Compostela, Santiago de Compostela, Spain., García-Closas M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA., Gerdes AM; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Glendon G; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada., Guénel P; Team 'Exposome and Heredity', CESP, Gustave Roussy, INSERM, University Paris-Saclay, UVSQ, Villejuif, France., Hahnen E; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Hamann U; Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hanson H; SouthWest Thames Centre for Genomics, St George's University Hospital's NHS Foundation Trust, London, UK., Hooning MJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Hoppe R; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tübingen, Tübingen, Germany., Izatt L; Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK., Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland., James PA; Parkville Familial Cancer Centre, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Kristensen VN; Department of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Lalloo F; Clinical Genetics Service, Manchester Centre for Genomic Medicine, Manchester University Hospitals Foundation Trust, Manchester, UK., Lindeman GJ; Parkville Familial Cancer Centre, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.; Department of Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia., Mannermaa A; Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.; Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.; Biobank of Eastern Finland, Kuopio University Hospital, Kuopio, Finland., Margolin S; Department of Oncology, Stockholm South General Hospital (Södersjukhuset), Stockholm, Sweden.; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden., Neuhausen SL; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA., Newman WG; Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.; North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Peterlongo P; Genome Diagnostics Program, IFOM ETS - The AIRC Institute of Molecular Oncology, Milan, Italy., Phillips KA; Department of Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.; Department of Medicine, St Vincent's Hospital, The University of Melbourne, Fitzroy, Victoria, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia., Pujana MA; Translational Research Laboratory, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, CIBERONC, Barcelona, Spain., Rantala J; Clinical Genetics, Karolinska Institutet, Stockholm, Sweden., Rønlund K; Department of Clinical Genetics, University Hospital of Southern Denmark, Vejle Hospital, Vejle, Denmark., Saloustros E; Department of Oncology, University Hospital of Larissa, Larissa, Greece., Schmutzler RK; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Schneeweiss A; National Center for Tumor Diseases, University Hospital and German Cancer Research Center, Heidelberg, Germany.; Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, University of Heidelberg, Heidelberg, Germany., Singer CF; Dept of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Suvanto M; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland., Tan YY; Dept of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Teixeira MR; Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.; School of Medicine and Biomedical Sciences (ICBAS), University of Porto, Porto, Portugal., Thomassen M; Department of Clinical Genetics, Odense University Hospital, Odence C, Denmark., Tischkowitz M; Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK., Tripathi V; Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK., Wappenschmidt B; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Zhao E; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Easton DF; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK., Chenevix-Trench G; Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Pharoah PDP; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK., Schmidt MK; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands., Blomqvist C; Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland., Nevanlinna H; Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

مؤلفون مشاركون: HEBON investigators

المصدر: NPJ breast cancer [NPJ Breast Cancer] 2023 May 12; Vol. 9 (1), pp. 37. Date of Electronic Publication: 2023 May 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

المؤلفون: Santana Dos Santos E; Department of Genetics, Institut Curie, 26 rue d'Ulm, Paris, France. elizabeth.santanadossantos@gmail.com.; Department of Medical Biology and Pathology, Gustave Roussy, Cancer Genetics Laboratory, Gustave Roussy, Villejuif, France. elizabeth.santanadossantos@gmail.com.; Department of Clinical Oncology, A.C. Camargo Cancer Center, São Paulo, Brazil. elizabeth.santanadossantos@gmail.com.; Department of Oncology, Center for Translational Oncology, Cancer Institute of the State of São Paulo - ICESP, São Paulo, Brazil. elizabeth.santanadossantos@gmail.com.; Centro de Oncologia Hospital Sírio Libanês-São Paulo, São Paulo, Brazil. elizabeth.santanadossantos@gmail.com., Spurdle AB; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Carraro DM; Molecular Biology and Genomics Group, A.C. Camargo Cancer Center, São Paulo, Brazil.; National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation, PSL Research University, Sao Paulo, Brazil., Briaux A; Department of Genetics, Institut Curie, 26 rue d'Ulm, Paris, France.; Research University, PSL, Paris, France., Southey M; Laboratory of Clinical Biology and Oncology, Centre François Baclesse, Inserm U1245 Genomics and Personalized Medicine in Cancer and Neurological Disorders, Normandy University, Caen, France.; Department of Pathology, The University of Melbourne, 3010, Victoria, Australia., Torrezan G; Molecular Biology and Genomics Group, A.C. Camargo Cancer Center, São Paulo, Brazil.; National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation, PSL Research University, Sao Paulo, Brazil., Petitalot A; Department of Genetics, Institut Curie, 26 rue d'Ulm, Paris, France.; Research University, PSL, Paris, France., Leman R; Laboratory of Clinical Biology and Oncology, Centre François Baclesse, Inserm U1245 Genomics and Personalized Medicine in Cancer and Neurological Disorders, Normandy University, Caen, France., Lafitte P; Department of Genetics, Institut Curie, 26 rue d'Ulm, Paris, France.; Research University, PSL, Paris, France., Meseure D; Department of Pathology, Institut Curie, 26 rue d'Ulm, Paris, France., Driouch K; Department of Genetics, Institut Curie, 26 rue d'Ulm, Paris, France.; Research University, PSL, Paris, France., Side L; Wessex Clinical Genetics Service, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Brewer C; Wessex Regional Genetics Laboratory, Salisbury NHS Foundation Trust, Salisbury, UK., Beck S; Wessex Clinical Genetics Service, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Melville A; Wessex Clinical Genetics Service, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Callaway A; Wessex Regional Genetics Laboratory, Salisbury NHS Foundation Trust, Salisbury, UK., Revillion F; Laboratory of Human Molecular Oncology - Centre Oscar Lambret, Lille Cedex, France., Folgueira MAAK; Department of Oncology, Center for Translational Oncology, Cancer Institute of the State of São Paulo - ICESP, São Paulo, Brazil., Parsons MT; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Thorne H; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Vincent-Salomon A; Department of Pathology, Institut Curie, 26 rue d'Ulm, Paris, France., Stoppa-Lyonnet D; Department of Genetics, Institut Curie, 26 rue d'Ulm, Paris, France.; Inserm U830, University Paris Descartes, Paris, France., Bieche I; Department of Genetics, Institut Curie, 26 rue d'Ulm, Paris, France.; Faculty of Pharmaceutical and Biological Sciences, University of Paris, F-75006, Paris, France., Caputo SM; Department of Genetics, Institut Curie, 26 rue d'Ulm, Paris, France.; Research University, PSL, Paris, France., Rouleau E; Department of Medical Biology and Pathology, Gustave Roussy, Cancer Genetics Laboratory, Gustave Roussy, Villejuif, France. etienne.rouleau@gustaveroussy.fr.

مؤلفون مشاركون: kConFab Investigators

المصدر: NPJ breast cancer [NPJ Breast Cancer] 2022 Jan 17; Vol. 8 (1), pp. 9. Date of Electronic Publication: 2022 Jan 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

المؤلفون: Muranen TA; University of Helsinki, Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland., Khan S; University of Helsinki, Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland.; University of Turku and Åbo Akademi University, Turku Bioscience Centre, Turku, Finland., Fagerholm R; University of Helsinki, Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland., Aittomäki K; University of Helsinki, Department of Clinical Genetics, Helsinki University Hospital, Helsinki, Finland., Cunningham JM; Mayo Clinic, Department of Laboratory Medicine and Pathology, Rochester, MN USA., Dennis J; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Leslie G; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., McGuffog L; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Parsons MT; QIMR Berghofer Medical Research Institute, Department of Genetics and Computational Biology, Brisbane, QLD Australia., Simard J; CHU de Quebec Research Center, Genomics Center, Québec City, QC Canada., Slager S; Mayo Clinic, Department of Health Sciences Research, Rochester, MN USA., Soucy P; CHU de Quebec Research Center, Genomics Center, Québec City, QC Canada., Easton DF; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK., Tischkowitz M; McGill University, Program in Cancer Genetics, Departments of Human Genetics and Oncology, Montréal, QC Canada.; University of Cambridge, Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK., Spurdle AB; QIMR Berghofer Medical Research Institute, Department of Genetics and Computational Biology, Brisbane, QLD Australia., Schmutzler RK; Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Hereditary Breast and Ovarian Cancer, Cologne, Germany.; Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany., Wappenschmidt B; Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Hereditary Breast and Ovarian Cancer, Cologne, Germany.; Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany., Hahnen E; Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Hereditary Breast and Ovarian Cancer, Cologne, Germany.; Faculty of Medicine and University Hospital Cologne, University of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany., Hooning MJ; Erasmus MC Cancer Institute, Department of Medical Oncology, Family Cancer Clinic, Rotterdam, The Netherlands., Singer CF; Medical University of Vienna, Dept of OB/GYN and Comprehensive Cancer Center, Vienna, Austria., Wagner G; Medical University of Vienna, Dept of OB/GYN and Comprehensive Cancer Center, Vienna, Austria., Thomassen M; Odense University Hospital, Department of Clinical Genetics, Odence C, Denmark., Pedersen IS; Aalborg University Hospital, Molecular Diagnostics, Aalborg, Denmark.; Aalborg University, Dept of Clinical Medicine, Aalborg, Denmark., Domchek SM; Perelman School of Medicine at the University of Pennsylvania, Department of Medicine, Abramson Cancer Center, Philadelphia, PA USA., Nathanson KL; Perelman School of Medicine at the University of Pennsylvania, Department of Medicine, Abramson Cancer Center, Philadelphia, PA USA., Lazaro C; ICO-IDIBELL (Bellvitge Biomedical Research Institute, Catalan Institute of Oncology), CIBERONC, Molecular Diagnostic Unit, Hereditary Cancer Program, Barcelona, Spain., Rossing CM; Rigshospitalet, Copenhagen University Hospital, Center for Genomic Medicine, Copenhagen, Denmark., Andrulis IL; Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics, Toronto, ON Canada.; University of Toronto, Department of Molecular Genetics, Toronto, ON Canada., Teixeira MR; Portuguese Oncology Institute, Department of Genetics, Porto, Portugal.; University of Porto, Biomedical Sciences Institute (ICBAS), Porto, Portugal., James P; Peter MacCallum Cancer Center, Parkville Familial Cancer Centre, Melbourne, VIC Australia.; The University of Melbourne, Sir Peter MacCallum Department of Oncology, Melbourne, VIC Australia., Garber J; Dana-Farber Cancer Institute, Cancer Risk and Prevention Clinic, Boston, MA USA., Weitzel JN; City of Hope, Clinical Cancer Genomics, Duarte, CA USA., Jakubowska A; Pomeranian Medical University, Department of Genetics and Pathology, Szczecin, Poland.; Pomeranian Medical University, Independent Laboratory of Molecular Biology and Genetic Diagnostics, Szczecin, Poland., Yannoukakos D; National Centre for Scientific Research 'Demokritos', Molecular Diagnostics Laboratory, INRASTES, Athens, Greece., John EM; Stanford Cancer Institute, Stanford University School of Medicine, Department of Medicine, Division of Oncology, Stanford, CA USA., Southey MC; Monash University, Precision Medicine, School of Clinical Sciences at Monash Health, Clayton, VIC Australia.; The University of Melbourne, Department of Clinical Pathology, Melbourne, VIC Australia., Schmidt MK; The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Division of Molecular Pathology, Amsterdam, The Netherlands.; The Netherlands Cancer Institute-Antoni van Leeuwenhoek hospital, Division of Psychosocial Research and Epidemiology, Amsterdam, The Netherlands., Antoniou AC; University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Chenevix-Trench G; QIMR Berghofer Medical Research Institute, Department of Genetics and Computational Biology, Brisbane, QLD Australia., Blomqvist C; University of Helsinki, Department of Oncology, Helsinki University Hospital, Helsinki, Finland.; Örebro University Hospital, Department of Oncology, Örebro, Sweden., Nevanlinna H; University of Helsinki, Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland.

مؤلفون مشاركون: kConFab Investigators, HEBON Investigators, SWE-BRCA Investigators

المصدر: NPJ breast cancer [NPJ Breast Cancer] 2020 Sep 10; Vol. 6, pp. 44. Date of Electronic Publication: 2020 Sep 10 (Print Publication: 2020).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: eCollection Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

المؤلفون: Figlioli G; IFOM - the FIRC Institute for Molecular Oncology, Genome Diagnostics Program, Milan, Italy., Bogliolo M; 2Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Bellaterra, Barcelona Spain.; 3Center for Biomedical Network Research on Rare Diseases (CIBERER), Madrid, Spain.; 4Institute of Biomedical Research, Sant Pau Hospital, Barcelona, Spain., Catucci I; IFOM - the FIRC Institute for Molecular Oncology, Genome Diagnostics Program, Milan, Italy., Caleca L; Fondazione IRCCS Istituto Nazionale dei Tumori, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Milan, Italy., Lasheras SV; 2Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Bellaterra, Barcelona Spain., Pujol R; 2Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Bellaterra, Barcelona Spain.; 3Center for Biomedical Network Research on Rare Diseases (CIBERER), Madrid, Spain.; 4Institute of Biomedical Research, Sant Pau Hospital, Barcelona, Spain., Kiiski JI; University of Helsinki, Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland., Muranen TA; University of Helsinki, Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland., Barnes DR; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Dennis J; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Michailidou K; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.; The Cyprus Institute of Neurology & Genetics, Department of Electron Microscopy/Molecular Pathology and The Cyprus School of Molecular Medicine, Nicosia, Cyprus., Bolla MK; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Leslie G; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Aalfs CM; 9Amsterdam UMC, lokatie AMC, Department of Clinical Genetics, Amsterdam, The Netherlands., Adank MA; The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Family Cancer Clinic, Amsterdam, The Netherlands., Adlard J; Chapel Allerton Hospital, Yorkshire Regional Genetics Service, Leeds, UK., Agata S; Veneto Institute of Oncology IOV - IRCCS, Immunology and Molecular Oncology Unit, Padua, Italy., Cadoo K; Memorial Sloan-Kettering Cancer Center, Department of Medicine, New York, NY USA., Agnarsson BA; Landspitali University Hospital, Department of Pathology, Reykjavik, Iceland.; 15University of Iceland, School of Medicine, Reykjavik, Iceland., Ahearn T; 16National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA., Aittomäki K; 17University of Helsinki, Department of Clinical Genetics, Helsinki University Hospital, Helsinki, Finland., Ambrosone CB; 18Roswell Park Cancer Institute, Buffalo, NY USA., Andrews L; Nelune Comprehensive Cancer Care Centre, The Bright Alliance Building, Randwick, NSW Australia., Anton-Culver H; 20University of California Irvine, Department of Epidemiology, Genetic Epidemiology Research Institute, Irvine, CA USA., Antonenkova NN; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus., Arndt V; German Cancer Research Center (DKFZ), Division of Clinical Epidemiology and Aging Research, Heidelberg, Germany., Arnold N; University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Department of Gynaecology and Obstetrics, and Institute of Clinical Molecular Biology, Kiel, Germany., Aronson KJ; Queen's University, Department of Public Health Sciences, and Cancer Research Institute, Kingston, ON Canada., Arun BK; 25University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX USA., Asseryanis E; 26Medical University of Vienna, Dept of OB/GYN and Comprehensive Cancer Center, Vienna, Austria., Auber B; 27Hannover Medical School, Institute of Human Genetics, Hannover, Germany., Auvinen P; 28Kuopio University Hospital, Cancer Center, Kuopio, Finland.; 29University of Eastern Finland, Institute of Clinical Medicine, Oncology, Kuopio, Finland.; 30University of Eastern Finland, Translational Cancer Research Area, Kuopio, Finland., Azzollini J; 31Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Department of Medical Oncology and Hematology, Unit of Medical Genetics, Milan, Italy., Balmaña J; 32Vall d'Hebron Institute of Oncology, High Risk and Cancer Prevention Group, Barcelona, Spain.; 33University Hospital, Vall d'Hebron, Department of Medical Oncology, Barcelona, Spain., Barkardottir RB; Landspitali University Hospital, Department of Pathology, Reykjavik, Iceland.; 34University of Iceland, BMC (Biomedical Centre), Faculty of Medicine, Reykjavik, Iceland., Barrowdale D; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Barwell J; 35University Hospitals of Leicester NHS Trust, Leicestershire Clinical Genetics Service, Leicester, UK., Beane Freeman LE; 16National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA., Beauparlant CJ; 36Centre Hospitalier Universitaire de Québec - Université Laval, Research Center, Genomics Center, Québec City, QC Canada., Beckmann MW; University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, Erlangen, Germany., Behrens S; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany., Benitez J; Spanish National Cancer Research Centre (CNIO), Human Genetics Group, Human Cancer Genetics Programme, Madrid, Spain.; 40Spanish Network on Rare Diseases (CIBERER), Madrid, Spain.; 41Spanish National Cancer Research Centre (CNIO), Genotyping Unit (CEGEN), Human Cancer Genetics Programme, Madrid, Spain., Berger R; Chaim Sheba Medical Center, The Institute of Oncology, Ramat Gan, Israel., Bermisheva M; 43Ufa Federal Research Center of the Russian Academy of Sciences, Institute of Biochemistry and Genetics, Ufa, Russia., Blanco AM; 44University of California San Francisco, Cancer Genetics and Prevention Program, San Francisco, CA USA., Blomqvist C; University of Helsinki, Department of Oncology, Helsinki University Hospital, Helsinki, Finland.; 46Örebro University Hospital, Department of Oncology, Örebro, Sweden., Bogdanova NV; N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.; Hannover Medical School, Department of Radiation Oncology, Hannover, Germany.; Hannover Medical School, Gynaecology Research Unit, Hannover, Germany., Bojesen A; 49Aarhus University Hospital, Department of Clinical Genetics, Aarhus, Denmark., Bojesen SE; Copenhagen University Hospital, Copenhagen General Population Study, Herlev and Gentofte Hospital, Herlev, Denmark.; Copenhagen University Hospital, Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Herlev, Denmark.; 52University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark., Bonanni B; 53IEO, European Institute of Oncology IRCCS, Division of Cancer Prevention and Genetics, Milan, Italy., Borg A; 54Lund University and Skåne University Hospital, Department of Oncology, Lund, Sweden., Brady AF; 55London North West University Hospitals NHS Trust, Northwick Park Hospital, North West Thames Regional Genetics Service, Kennedy Galton Centre, Harrow, UK., Brauch H; 56Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; 57University of Tübingen, iFIT-Cluster of Excellence, Tübingen, Germany.; 58German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany., Brenner H; German Cancer Research Center (DKFZ), Division of Clinical Epidemiology and Aging Research, Heidelberg, Germany.; 58German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.; 59German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Division of Preventive Oncology, Heidelberg, Germany., Brüning T; 60Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum, Bochum, Germany., Burwinkel B; 61German Cancer Research Center (DKFZ), Molecular Epidemiology Group, C080 Heidelberg, Germany.; University of Heidelberg, Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, Heidelberg, Germany., Buys SS; 63Huntsman Cancer Institute, Department of Medicine, Salt Lake City, UT USA., Caldés T; 64Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain., Caliebe A; University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Institute of Human Genetics, Kiel, Germany., Caligo MA; 66University Hospital of Pisa, Section of Molecular Genetics, Dept. of Laboratory Medicine, Pisa, Italy., Campa D; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany.; 67University of Pisa, Department of Biology, Pisa, Italy., Campbell IG; 68Peter MacCallum Cancer Center, Research Division, Melbourne, VIC Australia.; 69The University of Melbourne, Sir Peter MacCallum Department of Oncology, Melbourne, VIC Australia., Canzian F; 70German Cancer Research Center (DKFZ), Genomic Epidemiology Group, Heidelberg, Germany., Castelao JE; Instituto de Investigacion Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Oncology and Genetics Unit, Vigo, Spain., Chang-Claude J; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany.; 72University Medical Center Hamburg-Eppendorf, Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), Hamburg, Germany., Chanock SJ; 16National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA., Claes KBM; 73Ghent University, Centre for Medical Genetics, Gent, Belgium., Clarke CL; 74University of Sydney, Westmead Institute for Medical Research, Sydney, NSW Australia., Collavoli A; University and University Hospital of Pisa, Section of Genetic Oncology, Dept. of Laboratory Medicine, Pisa, Italy., Conner TA; 76Huntsman Cancer Institute, Salt Lake City, UT USA., Cox DG; 77Imperial College London, Department of Epidemiology and Biostatistics, School of Public Health, London, UK.; 78Cancer Research Center of Lyon, INSERM, U1052 Lyon, France., Cybulski C; 79Pomeranian Medical University, Department of Genetics and Pathology, Szczecin, Poland., Czene K; 80Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden., Daly MB; 81Fox Chase Cancer Center, Department of Clinical Genetics, Philadelphia, PA USA., de la Hoya M; 64Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain., Devilee P; 82Leiden University Medical Center, Department of Pathology, Leiden, The Netherlands.; 83Leiden University Medical Center, Department of Human Genetics, Leiden, The Netherlands., Diez O; 84Vall d'Hebron Institute of Oncology (VHIO), Oncogenetics Group, Barcelona, Spain.; 85University Hospital Vall d'Hebron, Area of Clinical and Molecular Genetics, Barcelona, Spain., Ding YC; 86Beckman Research Institute of City of Hope, Department of Population Sciences, Duarte, CA USA., Dite GS; 87The University of Melbourne, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Melbourne, Victoria, Australia., Ditsch N; 88Ludwig Maximilian University of Munich, Department of Gynecology and Obstetrics, Munich, Germany., Domchek SM; Perelman School of Medicine at the University of Pennsylvania, Department of Medicine, Abramson Cancer Center, Philadelphia, PA USA., Dorfling CM; 90University of Pretoria, Department of Genetics, Arcadia, South Africa., Dos-Santos-Silva I; 91London School of Hygiene and Tropical Medicine, Department of Non-Communicable Disease Epidemiology, London, UK., Durda K; 79Pomeranian Medical University, Department of Genetics and Pathology, Szczecin, Poland., Dwek M; 92University of Westminster, Department of Biomedical Sciences, Faculty of Science and Technology, London, UK., Eccles DM; 93University of Southampton, Cancer Sciences Academic Unit, Faculty of Medicine, Southampton, UK., Ekici AB; Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Institute of Human Genetics, University Hospital Erlangen, Erlangen, Germany., Eliassen AH; 95Harvard Medical School, Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA USA.; 96Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, MA USA., Ellberg C; 97Lund University, Department of Cancer Epidemiology, Clinical Sciences, Lund, Sweden., Eriksson M; 80Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden., Evans DG; 98University of Manchester, Division of Evolution and Genomic Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester, UK.; 99Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester Centre for Genomic Medicine, Manchester, UK., Fasching PA; University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, Erlangen, Germany.; 100University of California at Los Angeles, David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, Los Angeles, CA USA., Figueroa J; 16National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA.; 101The University of Edinburgh Medical School, Usher Institute of Population Health Sciences and Informatics, Edinburgh, UK.; Cancer Research UK Edinburgh Centre, Edinburgh, UK., Flyger H; Copenhagen University Hospital, Department of Breast Surgery, Herlev and Gentofte Hospital, Herlev, Denmark., Foulkes WD; 104McGill University, Program in Cancer Genetics, Departments of Human Genetics and Oncology, Montréal, QC Canada., Friebel TM; 105Harvard T.H. Chan School of Public Health, Boston, MA USA.; 106Dana-Farber Cancer Institute, Boston, MA USA., Friedman E; 107Chaim Sheba Medical Center, The Susanne Levy Gertner Oncogenetics Unit, Ramat Gan, Israel.; 108Tel Aviv University, Sackler Faculty of Medicine, Ramat Aviv, Israel., Gabrielson M; 80Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden., Gaddam P; 109Memorial Sloan-Kettering Cancer Center, Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, New York, NY USA., Gago-Dominguez M; 110Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Genomic Medicine Group, Galician Foundation of Genomic Medicine, Santiago de Compostela, Spain.; 111University of California San Diego, Moores Cancer Center, La Jolla, CA USA., Gao C; 112Harvard T.H. Chan School of Public Health, Program in Genetic Epidemiology and Statistical Genetics, Boston, MA USA., Gapstur SM; 113American Cancer Society, Epidemiology Research Program, Atlanta, GA USA., Garber J; Dana-Farber Cancer Institute, Cancer Risk and Prevention Clinic, Boston, MA USA., García-Closas M; 16National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA., García-Sáenz JA; 64Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain., Gaudet MM; 113American Cancer Society, Epidemiology Research Program, Atlanta, GA USA., Gayther SA; 116Cedars-Sinai Medical Center, The Center for Bioinformatics and Functional Genomics at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA USA., Giles GG; 87The University of Melbourne, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Melbourne, Victoria, Australia.; 117Cancer Council Victoria, Cancer Epidemiology Division, Melbourne, VIC Australia.; 118Monash University, Department of Epidemiology and Preventive Medicine, Melbourne, VIC Australia., Glendon G; 119Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics, Toronto, ON Canada., Godwin AK; 120Kansas University Medical Center, Department of Pathology and Laboratory Medicine, Kansas City, KS USA., Goldberg MS; 121McGill University, Department of Medicine, Montréal, QC Canada.; 122McGill University, Division of Clinical Epidemiology, Royal Victoria Hospital, Montréal, QC Canada., Goldgar DE; 123Huntsman Cancer Institute, University of Utah School of Medicine, Department of Dermatology, Salt Lake City, UT USA., Guénel P; 124INSERM, University Paris-Sud, University Paris-Saclay, Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), Villejuif, France., Gutierrez-Barrera AM; 125University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology and Clinical Genetics Program, Houston, TX USA., Haeberle L; 126Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Department of Gynaecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany., Haiman CA; 127University of Southern California, Department of Preventive Medicine, Keck School of Medicine, Los Angeles, CA USA., Håkansson N; 128Karolinska Institutet, Institute of Environmental Medicine, Stockholm, Sweden., Hall P; 80Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden.; 129Södersjukhuset, Department of Oncology, Stockholm, Sweden., Hamann U; German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, Heidelberg, Germany., Harrington PA; 131University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK., Hein A; University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, Erlangen, Germany., Heyworth J; 132The University of Western Australia, School of Population and Global Health, Perth, WA Australia., Hillemanns P; Hannover Medical School, Gynaecology Research Unit, Hannover, Germany., Hollestelle A; 133Erasmus MC Cancer Institute, Department of Medical Oncology, Family Cancer Clinic, Rotterdam, The Netherlands., Hopper JL; 87The University of Melbourne, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Melbourne, Victoria, Australia., Hosgood HD 3rd; 134Albert Einstein College of Medicine, Department of Epidemiology and Public Health, Bronx, NY USA., Howell A; 135University of Manchester, Division of Cancer Sciences, Manchester, UK., Hu C; 136Mayo Clinic, Department of Laboratory Medicine and Pathology, Rochester, MN USA., Hulick PJ; 137NorthShore University HealthSystem, Center for Medical Genetics, Evanston, IL USA.; 138The University of Chicago Pritzker School of Medicine, Chicago, IL USA., Hunter DJ; 96Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, MA USA.; 112Harvard T.H. Chan School of Public Health, Program in Genetic Epidemiology and Statistical Genetics, Boston, MA USA.; 139University of Oxford, Nuffield Department of Population Health, Oxford, UK., Imyanitov EN; 140N.N. Petrov Institute of Oncology, St. Petersburg, Russia., Isaacs C; 141Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC USA., Jakimovska M; 142Macedonian Academy of Sciences and Arts, Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', Skopje, Republic of Macedonia., Jakubowska A; 79Pomeranian Medical University, Department of Genetics and Pathology, Szczecin, Poland.; 143Pomeranian Medical University, Independent Laboratory of Molecular Biology and Genetic Diagnostics, Szczecin, Poland., James P; 69The University of Melbourne, Sir Peter MacCallum Department of Oncology, Melbourne, VIC Australia.; 144Peter MacCallum Cancer Center, Parkville Familial Cancer Centre, Melbourne, VIC Australia., Janavicius R; 145Vilnius University Hospital Santariskiu Clinics, Hematology, oncology and transfusion medicine center, Dept. of Molecular and Regenerative Medicine, Vilnius, Lithuania.; State Research Institute Innovative Medicine Center, Vilnius, Lithuania., Janni W; 147University Hospital Ulm, Department of Gynaecology and Obstetrics, Ulm, Germany., John EM; 148Stanford University School of Medicine, Department of Medicine (Oncology) and Stanford Cancer Institute, Stanford, CA USA., Jones ME; 115The Institute of Cancer Research, Division of Genetics and Epidemiology, London, UK., Jung A; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany., Kaaks R; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany., Karlan BY; 149Cedars-Sinai Medical Center, Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA USA., Khusnutdinova E; 43Ufa Federal Research Center of the Russian Academy of Sciences, Institute of Biochemistry and Genetics, Ufa, Russia.; 150Bashkir State Medical University, Department of Medical Genetics, Ufa, Russia., Kitahara CM; 151National Cancer Institute, Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA., Konstantopoulou I; 152National Centre for Scientific Research 'Demokritos', Molecular Diagnostics Laboratory, INRASTES, Athens, Greece., Koutros S; 16National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA., Kraft P; 96Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, MA USA.; 112Harvard T.H. Chan School of Public Health, Program in Genetic Epidemiology and Statistical Genetics, Boston, MA USA., Lambrechts D; 153VIB, VIB Center for Cancer Biology, Leuven, Belgium.; 154University of Leuven, Laboratory for Translational Genetics, Department of Human Genetics, Leuven, Belgium., Lazaro C; IDIBELL (Bellvitge Biomedical Research Institute),Catalan Institute of Oncology, CIBERONC, Molecular Diagnostic Unit, Hereditary Cancer Program, Barcelona, Spain., Le Marchand L; 156University of Hawaii Cancer Center, Epidemiology Program, Honolulu, HI USA., Lester J; 149Cedars-Sinai Medical Center, Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA USA., Lesueur F; Inserm U900, Genetic Epidemiology of Cancer team, Paris, France.; 158PSL University, Paris, France.; 159Institut Curie, Paris, France.; 160Mines ParisTech, Fontainebleau, France., Lilyquist J; 161Mayo Clinic, Department of Health Sciences Research, Rochester, MN USA., Loud JT; 162National Cancer Institute, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA., Lu KH; 163University of Texas MD Anderson Cancer Center, Department of Gynecologic Oncology and Clinical Cancer Genetics Program, Houston, TX USA., Luben RN; 164University of Cambridge, Clinical Gerontology, Department of Public Health and Primary Care, Cambridge, UK., Lubinski J; 79Pomeranian Medical University, Department of Genetics and Pathology, Szczecin, Poland., Mannermaa A; 30University of Eastern Finland, Translational Cancer Research Area, Kuopio, Finland.; 165University of Eastern Finland, Institute of Clinical Medicine, Pathology and Forensic Medicine, Kuopio, Finland.; 166Kuopio University Hospital, Imaging Center, Department of Clinical Pathology, Kuopio, Finland., Manoochehri M; German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, Heidelberg, Germany., Manoukian S; 31Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Department of Medical Oncology and Hematology, Unit of Medical Genetics, Milan, Italy., Margolin S; 129Södersjukhuset, Department of Oncology, Stockholm, Sweden.; Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset, Stockholm, Sweden., Martens JWM; 133Erasmus MC Cancer Institute, Department of Medical Oncology, Family Cancer Clinic, Rotterdam, The Netherlands., Maurer T; 72University Medical Center Hamburg-Eppendorf, Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), Hamburg, Germany., Mavroudis D; 168University Hospital of Heraklion, Department of Medical Oncology, Heraklion, Greece., Mebirouk N; Inserm U900, Genetic Epidemiology of Cancer team, Paris, France.; 158PSL University, Paris, France.; 159Institut Curie, Paris, France.; 160Mines ParisTech, Fontainebleau, France., Meindl A; 88Ludwig Maximilian University of Munich, Department of Gynecology and Obstetrics, Munich, Germany., Menon U; University College London, MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, London, UK., Miller A; Roswell Park Cancer Institute, NRG Oncology, Clinical Trials Development Division, Buffalo, NY USA., Montagna M; Veneto Institute of Oncology IOV - IRCCS, Immunology and Molecular Oncology Unit, Padua, Italy., Nathanson KL; Perelman School of Medicine at the University of Pennsylvania, Department of Medicine, Abramson Cancer Center, Philadelphia, PA USA., Neuhausen SL; 86Beckman Research Institute of City of Hope, Department of Population Sciences, Duarte, CA USA., Newman WG; 98University of Manchester, Division of Evolution and Genomic Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester, UK.; 99Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester Centre for Genomic Medicine, Manchester, UK., Nguyen-Dumont T; 171Monash University, Precision Medicine, School of Clinical Sciences at Monash Health, Clayton, VIC Australia.; 199The University of Melbourne, Department of Clinical Pathology, Melbourne, VIC Australia., Nielsen FC; Rigshospitalet, Copenhagen University Hospital, Center for Genomic Medicine, Copenhagen, Denmark., Nielsen S; The University of Chicago, Center for Clinical Cancer Genetics, Chicago, IL USA., Nikitina-Zake L; 174Latvian Biomedical Research and Study Centre, Riga, Latvia., Offit K; 109Memorial Sloan-Kettering Cancer Center, Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, New York, NY USA.; 175Memorial Sloan-Kettering Cancer Center, Clinical Genetics Service, Department of Medicine, New York, NY USA., Olah E; 176National Institute of Oncology, Department of Molecular Genetics, Budapest, Hungary., Olopade OI; The University of Chicago, Center for Clinical Cancer Genetics, Chicago, IL USA., Olshan AF; 177University of North Carolina at Chapel Hill, Department of Epidemiology, Lineberger Comprehensive Cancer Center, Chapel Hill, NC USA., Olson JE; 161Mayo Clinic, Department of Health Sciences Research, Rochester, MN USA., Olsson H; 97Lund University, Department of Cancer Epidemiology, Clinical Sciences, Lund, Sweden., Osorio A; Spanish National Cancer Research Centre (CNIO), Human Genetics Group, Human Cancer Genetics Programme, Madrid, Spain.; 40Spanish Network on Rare Diseases (CIBERER), Madrid, Spain., Ottini L; 178University La Sapienza, Department of Molecular Medicine, Rome, Italy., Peissel B; 31Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Department of Medical Oncology and Hematology, Unit of Medical Genetics, Milan, Italy., Peixoto A; 179Portuguese Oncology Institute, Department of Genetics, Porto, Portugal., Peto J; 91London School of Hygiene and Tropical Medicine, Department of Non-Communicable Disease Epidemiology, London, UK., Plaseska-Karanfilska D; 142Macedonian Academy of Sciences and Arts, Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', Skopje, Republic of Macedonia., Pocza T; 176National Institute of Oncology, Department of Molecular Genetics, Budapest, Hungary., Presneau N; 92University of Westminster, Department of Biomedical Sciences, Faculty of Science and Technology, London, UK., Pujana MA; IDIBELL (Bellvitge Biomedical Research Institute),Catalan Institute of Oncology, CIBERONC, ProCURE, Oncobell, Barcelona, Spain., Punie K; 181Leuven Cancer Institute, University Hospitals Leuven, Multidisciplinary Breast Center, Department of General Medical Oncology, Leuven, Belgium., Rack B; 147University Hospital Ulm, Department of Gynaecology and Obstetrics, Ulm, Germany., Rantala J; 182Karolinska Institutet, Clinical Genetics, Stockholm, Sweden., Rashid MU; German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, Heidelberg, Germany.; 183Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Department of Basic Sciences, Lahore, Pakistan., Rau-Murthy R; 175Memorial Sloan-Kettering Cancer Center, Clinical Genetics Service, Department of Medicine, New York, NY USA., Rennert G; 184Carmel Medical Center and Technion Faculty of Medicine, Clalit National Cancer Control Center, Haifa, Israel., Lejbkowicz F; 184Carmel Medical Center and Technion Faculty of Medicine, Clalit National Cancer Control Center, Haifa, Israel., Rhenius V; 131University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK., Romero A; 185Hospital Universitario Puerta de Hierro, Medical Oncology Department, Madrid, Spain., Rookus MA; 186The Netherlands Cancer Institute, Department of Epidemiology, Amsterdam, The Netherlands., Ross EA; 187Fox Chase Cancer Center, Biostatistics and Bioinformatics Facility, Philadelphia, PA USA., Rossing M; Rigshospitalet, Copenhagen University Hospital, Center for Genomic Medicine, Copenhagen, Denmark., Rudaitis V; 188Vilnius University, Medical Faculty, Institute of Clinical Medicine, Vilnius, Lithuania., Ruebner M; 126Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Department of Gynaecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany., Saloustros E; 189University Hospital of Larissa, Department of Oncology, Larissa, Greece., Sanden K; 190University of Wisconsin, Cancer Center at ProHealth Care, Waukesha, WI USA., Santamariña M; 40Spanish Network on Rare Diseases (CIBERER), Madrid, Spain.; 191Fundación Pública Galega Medicina Xenómica, Santiago De Compostela, Spain.; 192Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago De Compostela, Spain., Scheuner MT; 44University of California San Francisco, Cancer Genetics and Prevention Program, San Francisco, CA USA., Schmutzler RK; 193University Hospital of Cologne, Center for Hereditary Breast and Ovarian Cancer, Cologne, Germany.; 194University of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany., Schneider M; 126Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Department of Gynaecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany., Scott C; 161Mayo Clinic, Department of Health Sciences Research, Rochester, MN USA., Senter L; 195The Ohio State University, Clinical Cancer Genetics Program, Division of Human Genetics, Department of Internal Medicine, The Comprehensive Cancer Center, Columbus, OH USA., Shah M; 131University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK., Sharma P; 196University of Kansas Medical Center, Department of Internal Medicine, Division of Oncology, Westwood, KS USA., Shu XO; Vanderbilt University School of Medicine, Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Nashville, TN USA., Simard J; 36Centre Hospitalier Universitaire de Québec - Université Laval, Research Center, Genomics Center, Québec City, QC Canada., Singer CF; 26Medical University of Vienna, Dept of OB/GYN and Comprehensive Cancer Center, Vienna, Austria., Sohn C; University of Heidelberg, National Center for Tumor Diseases, Heidelberg, Germany., Soucy P; 36Centre Hospitalier Universitaire de Québec - Université Laval, Research Center, Genomics Center, Québec City, QC Canada., Southey MC; 171Monash University, Precision Medicine, School of Clinical Sciences at Monash Health, Clayton, VIC Australia.; 199The University of Melbourne, Department of Clinical Pathology, Melbourne, VIC Australia., Spinelli JJ; BC Cancer, Population Oncology, Vancouver, BC Canada.; 201University of British Columbia, School of Population and Public Health, Vancouver, BC Canada., Steele L; 86Beckman Research Institute of City of Hope, Department of Population Sciences, Duarte, CA USA., Stoppa-Lyonnet D; 202Institut Curie, Service de Génétique, Paris, France.; INSERM U830, Department of Tumour Biology, Paris, France.; 204Université Paris Descartes, Paris, France., Tapper WJ; 205University of Southampton, Faculty of Medicine, Southampton, UK., Teixeira MR; 179Portuguese Oncology Institute, Department of Genetics, Porto, Portugal.; 206University of Porto, Biomedical Sciences Institute (ICBAS), Porto, Portugal., Terry MB; 207Columbia University, Department of Epidemiology, Mailman School of Public Health, New York, NY USA., Thomassen M; 208Odense University Hospital, Department of Clinical Genetics, Odence C, Denmark., Thompson J; 137NorthShore University HealthSystem, Center for Medical Genetics, Evanston, IL USA., Thull DL; Magee-Womens Hospital, University of Pittsburgh School of Medicine, Department of Medicine, Pittsburgh, PA USA., Tischkowitz M; 104McGill University, Program in Cancer Genetics, Departments of Human Genetics and Oncology, Montréal, QC Canada.; 210University of Cambridge, Department of Medical Genetics, Cambridge, UK., Tollenaar RAEM; 211Leiden University Medical Center, Department of Surgery, Leiden, The Netherlands., Torres D; German Cancer Research Center (DKFZ), Molecular Genetics of Breast Cancer, Heidelberg, Germany.; 212Pontificia Universidad Javeriana, Institute of Human Genetics, Bogota, Colombia., Troester MA; 177University of North Carolina at Chapel Hill, Department of Epidemiology, Lineberger Comprehensive Cancer Center, Chapel Hill, NC USA., Truong T; 124INSERM, University Paris-Sud, University Paris-Saclay, Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), Villejuif, France., Tung N; 213Beth Israel Deaconess Medical Center, Department of Medical Oncology, Boston, MA USA., Untch M; Helios Clinics Berlin-Buch, Department of Gynecology and Obstetrics, Berlin, Germany., Vachon CM; 161Mayo Clinic, Department of Health Sciences Research, Rochester, MN USA., van Rensburg EJ; 90University of Pretoria, Department of Genetics, Arcadia, South Africa., van Veen EM; 98University of Manchester, Division of Evolution and Genomic Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester, UK.; 99Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester Centre for Genomic Medicine, Manchester, UK., Vega A; 40Spanish Network on Rare Diseases (CIBERER), Madrid, Spain.; 191Fundación Pública Galega Medicina Xenómica, Santiago De Compostela, Spain.; 192Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago De Compostela, Spain., Viel A; 215Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Division of Functional onco-genomics and genetics, Aviano, Italy., Wappenschmidt B; 193University Hospital of Cologne, Center for Hereditary Breast and Ovarian Cancer, Cologne, Germany.; 194University of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany., Weitzel JN; 216City of Hope, Clinical Cancer Genetics, Duarte, CA USA., Wendt C; 129Södersjukhuset, Department of Oncology, Stockholm, Sweden.; Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset, Stockholm, Sweden., Wieme G; 73Ghent University, Centre for Medical Genetics, Gent, Belgium., Wolk A; 128Karolinska Institutet, Institute of Environmental Medicine, Stockholm, Sweden.; 217Uppsala University, Department of Surgical Sciences, Uppsala, Sweden., Yang XR; 16National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA., Zheng W; Vanderbilt University School of Medicine, Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Nashville, TN USA., Ziogas A; 20University of California Irvine, Department of Epidemiology, Genetic Epidemiology Research Institute, Irvine, CA USA., Zorn KK; Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA USA., Dunning AM; 131University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK., Lush M; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Wang Q; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., McGuffog L; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Parsons MT; 219QIMR Berghofer Medical Research Institute, Department of Genetics and Computational Biology, Brisbane, QLD Australia., Pharoah PDP; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.; 131University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK., Fostira F; 152National Centre for Scientific Research 'Demokritos', Molecular Diagnostics Laboratory, INRASTES, Athens, Greece., Toland AE; 220The Ohio State University, Department of Cancer Biology and Genetics, Columbus, OH USA., Andrulis IL; 119Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics, Toronto, ON Canada.; 221University of Toronto, Department of Molecular Genetics, Toronto, ON Canada., Ramus SJ; 222University of NSW Sydney, School of Women's and Children's Health, Faculty of Medicine, Sydney, NSW Australia.; 223The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, NSW Australia., Swerdlow AJ; The Institute of Cancer Research, Division of Genetics and Epidemiology, London, UK.; The Institute of Cancer Research, Division of Breast Cancer Research, London, UK., Greene MH; 162National Cancer Institute, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, Bethesda, MD USA., Chung WK; 226Columbia University, Departments of Pediatrics and Medicine, New York, NY USA., Milne RL; 87The University of Melbourne, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Melbourne, Victoria, Australia.; 117Cancer Council Victoria, Cancer Epidemiology Division, Melbourne, VIC Australia.; 171Monash University, Precision Medicine, School of Clinical Sciences at Monash Health, Clayton, VIC Australia., Chenevix-Trench G; 219QIMR Berghofer Medical Research Institute, Department of Genetics and Computational Biology, Brisbane, QLD Australia., Dörk T; Hannover Medical School, Gynaecology Research Unit, Hannover, Germany., Schmidt MK; 227The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Division of Molecular Pathology, Amsterdam, The Netherlands.; 228The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Division of Psychosocial Research and Epidemiology, Amsterdam, The Netherlands., Easton DF; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK.; 131University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Oncology, Cambridge, UK., Radice P; Fondazione IRCCS Istituto Nazionale dei Tumori, Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Milan, Italy., Hahnen E; 193University Hospital of Cologne, Center for Hereditary Breast and Ovarian Cancer, Cologne, Germany.; 194University of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany., Antoniou AC; 7University of Cambridge, Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Cambridge, UK., Couch FJ; 136Mayo Clinic, Department of Laboratory Medicine and Pathology, Rochester, MN USA., Nevanlinna H; University of Helsinki, Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland., Surrallés J; 2Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Bellaterra, Barcelona Spain.; 3Center for Biomedical Network Research on Rare Diseases (CIBERER), Madrid, Spain.; 4Institute of Biomedical Research, Sant Pau Hospital, Barcelona, Spain.; 229Department of Genetics, Sant Pau Hospital, Barcelona, Spain., Peterlongo P; IFOM - the FIRC Institute for Molecular Oncology, Genome Diagnostics Program, Milan, Italy.

مؤلفون مشاركون: ABCTB Investigators, GEMO Study Collaborators, KConFab

المصدر: NPJ breast cancer [NPJ Breast Cancer] 2019 Nov 01; Vol. 5, pp. 38. Date of Electronic Publication: 2019 Nov 01 (Print Publication: 2019).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: eCollection Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE